Before you sell to, join or invest in Nurocor Inc
MentionFox check on Nurocor Inc: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/nurocor-inc-form-d-25000002
Check Nurocor Inc before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Nurocor Inc?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Nurocor Inc filed a Form D with the Securities and Exchange Commission on 2025-04-02.
Nurocor Inc filed a Form D notice of an exempt securities offering with the SEC on April 2, 2025. The filing reports $500K sold. Its industry group is Other Technology. It names Paul Gigg (Executive Officer, Director), Alex Lazar (Executive Officer, Director), Gregg Martin (Executive Officer, Director) (SEC Form D, April 2, 2025).
Is this your company?
Sell to companies like Nurocor Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-02 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Nurocor Inc.
Free to see. No signup.
More on the people and the money behind Nurocor Inc, from the filings we hold.
Other Technology raises by companies based in Texas, filed in April 2025, largest first.
Get an email when Nurocor Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Nurocor Inc raises, hires or launches. No email unless you switch it on.
Watch Nurocor Inc →Get the full cited report on Nurocor Inc
What the filing shows about Nurocor Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Nurocor Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Nurocor Inc's address as 100 Congress Ave., Suite 2000, Austin, TX 78701.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Nurocor Inc is a registered filer with the SEC (CIK 1931921) and has filed since 2024-10-17. 6 filings are on record, the latest on 2025-05-22.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Nurocor Inc's Form D of 2025-04-02 names Paul Gigg, Alex Lazar and Gregg Martin as its officers, directors or promoters.
Its new offerings report $6.63M sold across 6 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 3839 filings in Other Technology, totalled by week.
Paul Gigg is named as Executive Officer and Director on the Form D that Nurocor Inc filed with the SEC on 2 April 2025, one of 3 people that filing names.
Alex Lazar is named as Executive Officer and Director on the Form D that Nurocor Inc filed with the SEC on 2 April 2025, one of 3 people that filing names.
Gregg Martin is named as Executive Officer and Director on the Form D that Nurocor Inc filed with the SEC on 2 April 2025, one of 3 people that filing names.
3 people named on the filing — 3 holding an executive role.
Named as of the 2025-04-02 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Nurocor Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Nurocor Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Nurocor Inc covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Nurocor IncYou get an alert in MentionFox the next time this company shows up.
If you're behind Nurocor Inc: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Nurocor Inc. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in Austin
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/nurocor-inc-form-d-25000002